- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 23, 2026 | 29.03M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $0 |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $0 |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $66.97M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $67.64M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $133.55M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $135.91M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $172.4M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $176.97M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $120.22M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $136.54M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $159.29M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $173.73M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 27.85M sh |
| Capex restated | Q1 2025 · Mar 31, 2024 | $1.53M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$15.88M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | $44.98M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | $61.13M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.66 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$0.66 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $7.43M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $10.8M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$18.45M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$15.58M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $14.01M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $33.06M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $47.07M |